Page 100 - Fertility in Women with Rheumatoid Arthritis Vruchtbaarheid van vrouwen met reumatoïde artritis

Chapter 6
REFERENCES
1. Clowse ME, Chakravarty E, Costenbader KH, Chambers C, Michaud K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012 May;64(5):668-74.
2. Brouwer J, Hazes JM, Laven JS, Dolhain RJ. Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis. 2015 Oct;74(10):1836-41.
3. Brouwer J, Fleurbaaij R, Hazes JM, Laven JS, Dolhain RJ. OP0165 Subfertility in Female Rheumatoid Arthritis Patients is Often Unexplained or Caused by Anovulation. Annals of the rheumatic diseases. 2015 June 1, 2015;74(Suppl 2):131-2.
4. Del Junco DJ, Annegers JF, Coulam CB, Luthra HS. The relationship between rheumatoid arthritis and reproductive function. Br J Rheumatol. 1989;28 Suppl 1:33; discussion 42-5.
5. Kay A, Bach F. Subfertility before and after the Development of Rheumatoid Arthritis in Women. Ann Rheum Dis. 1965 Mar;24:169-73.
6. Luisi S, Orlandini C, Regini C, Pizzo A, Vellucci F, Petraglia F. Premature ovarian insuf ciency: from pathogenesis to clinical management. J Endocrinol Invest. 2015 Jun;38(6):597-603.
7. Saglam F, Onal ED, Ersoy R, Koca C, Ergin M, Erel O, et al. Anti-Mullerian hormone as a marker of premature ovarian aging in autoimmune thyroid disease. Gynecol Endocrinol. 2015 Feb;31(2):165-8.
8. Henes M, Froeschlin J, Taran FA, Brucker S, Rall KK, Xenitidis T, et al. Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behcet’s disease and spondyloarthritis on anti-Mullerian hormone levels. Rheumatology (Oxford). 2015 Sep;54(9):1709-12.
9. te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002 Mar- Apr;8(2):141-54.
10. Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction. 2006 Jan;131(1):1-9.
11. Weenen C, Laven JS, Von Bergh AR, Cran eld M, Groome NP, Visser JA, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004 Feb;10(2):77-83.
12. Lie Fong S, Visser JA, Welt CK, de Rijke YB, Eijkemans MJ, Broekmans FJ, et al. Serum anti-mullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab. 2012 Dec;97(12):4650-5.
13. Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014 May-Jun;20(3):370-85.
14. Plante BJ, Beamon C, Schmitt CL, Moldenhauer JS, Steiner AZ. Maternal antimullerian hormone levels do not predict fetal aneuploidy. J Assist Reprod Genet. 2010 Jul;27(7):409-14.
15. Nelson SM, Stewart F, Fleming R, Freeman DJ. Longitudinal assessment of antimullerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin. Fertil Steril. 2010 Mar 1;93(4):1356-8.
16. Li HW, Hui PW, Tang MH, Lau ET, Yeung WS, Ho PC, et al. Maternal serum anti-Mullerian hormone level is not superior to chronological age in predicting Down syndrome pregnancies. Prenat Diagn. 2010 Apr;30(4):320-4.
17. Koninger A, Kauth A, Schmidt B, Schmidt M, Yerlikaya G, Kasimir-Bauer S, et al. Anti-Mullerian-hormone levels during pregnancy and postpartum. Reprod Biol Endocrinol. 2013 Jul 11;11(1):60.
18. Broer SL, Eijkemans MJ, Scheffer GJ, van Rooij IA, de Vet A, Themmen AP, et al. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011 Aug;96(8):2532-9.
19. Nelson SM, Fleming R, Gaudoin M, Choi B, Santo-Domingo K, Yao M. Antimullerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth. Fertil Steril. 2015 Aug;104(2):325-32.
20. Kamel HM, Amin AH, Al-Adawy AR. Basal serum anti-Mullerian hormone (AMH) is a promising test in prediction of occurrence of pregnancy rate in infertile women undergoing ICSI cycles. Clin Lab. 2014;60(10):1717-23.
98